Nat. Biotechnol. 27, 103–104 (2009); published online 9 February 2009; corrected after print 8 July 2009
In the version of this article initially published, “GSK Ventures” should have read “GlaxoSmithKline's SR One.” The error has been corrected in the HTML and PDF versions of the article.
Additional information
The online version of the original article can be found at 10.1038/nbt0209-103
Rights and permissions
About this article
Cite this article
Mitchell, P. Erratum: Venture capital shifts strategies, startups suffer. Nat Biotechnol 27, 671 (2009). https://doi.org/10.1038/nbt0709-671b
Issue Date:
DOI: https://doi.org/10.1038/nbt0709-671b
